Mentioned in ?
References in periodicals archive ?
Stallergenes Greer is a global healthcare company specializing in the diagnosis and treatment of allergies through the development and commercialization of allergy immunotherapy products and services.
Medic Savoure commercialises a full range of allergy immunotherapy products, including diagnostic and AIT treatment products throughout Canada.
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.
Given that subcutaneous immunotherapy is the mainstay of therapy in North America for seasonal allergic rhinoconjunctivitis and mild asthma that is unresponsive to pharmacotherapy, this ragweed sublingual allergy immunotherapy liquid (RWSAIL) extract could represent an important and more convenient option for the management of allergic respiratory disease.
GREER is committed to advancing allergy immunotherapy and we look forward to taking the next steps in the process to gain the necessary governmental agency approvals for GREER SAIL.
In summary, research has demonstrated that allergy immunotherapy can not only be effective in treating symptoms of allergic asthma and rhinitis, but also it is cost-effective.
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.
SEATTLE -- The Cost of allergy immunotherapy among children with allergic rhinitis is quickly surpassed by savings in other health care costs, new data suggest.
The study compared the costs before and after allergy immunotherapy (injections), based on the Medicaid records of 520 low-income Florida children.
R&D teams are striving to create new formulations and delivery methods for allergy immunotherapy treatments.
Greer, a leading provider of allergy immunotherapy products and services, introduces the Skintestor OMNI[TM] allergy tray, to be used with the company's Skintestor OMNI[TM] skin-testing device.
Only two therapies make the grade as having an "appreciable" effect by achieving a greater than 40% reduction in symptom scores beyond placebo: nasal steroids and allergy immunotherapy.

Full browser ?